Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Stock indices serve as market barometers, benchmarks, and investment guides. Learn how they inform decisions and performance tracking.
17,462 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Salesforce posted a stronger-than-expected quarter, delivering an EPS beat and stronger cash flow. The company unveil...
Investors watch the moves of billionaires to learn how they navigate risk and opportunity. This piece breaks down how...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...
As Toro prepares to report and discuss its 2026 earnings, investors want clarity on demand, margins, and guidance. Th...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...
A diversified quartet of high-yield ETFs aims to deliver monthly income above 6%. This piece breaks down how they wor...
Investors are eyeing aemetis (amtx) 2025 earnings as the company advances its biofuels and biochemicals projects. Thi...
Nebius inked a $27 billion AI infrastructure deal with Meta, locking in vast capacity and signaling its edge in the n...
Is GE Vernova the vernova smartest investment make for your portfolio? This comprehensive guide breaks down the busin...
Big tech often steals the AI spotlight, but overlooked, nimble players could outperform. This guide breaks down the r...
Alibaba's profits falling here's headlines grab attention, but the real story is a company in transition. This guide ...